Company Filing History:
Years Active: 2013
Title: Mihaly Daniel Gardiner: Innovator in Hsp90 Inhibitors
Introduction
Mihaly Daniel Gardiner is a notable inventor based in Oxfordshire, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Gardiner holds a patent for "Quinazolin-oxime derivatives as Hsp90 inhibitors." This patent describes compounds of general formula (I), including their stereoisomers, tautomers, pharmaceutically acceptable salts, or prodrugs. These compounds are designed to treat diseases and conditions mediated by excessive or inappropriate Hsp90 activity, such as cancers, viral infections, and inflammatory diseases.
Career Highlights
Mihaly Daniel Gardiner is associated with Dac Slr, where he applies his expertise in drug development. His work focuses on creating innovative solutions to combat serious health issues through targeted therapies.
Collaborations
Gardiner collaborates with esteemed colleagues, including Stephen Martin Courtney and Mark Whittaker. Their combined efforts contribute to advancing research in the field of Hsp90 inhibitors.
Conclusion
Mihaly Daniel Gardiner's work exemplifies the impact of innovative research in the pharmaceutical industry. His contributions to Hsp90 inhibitors highlight the importance of targeted therapies in treating complex diseases.